Net Cash Provided by (Used in) Operating Activities |
-123 K |
USD |
+64.1% |
Q2 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
700 K |
USD |
|
Q2 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-322 K |
USD |
|
Q2 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
15 M |
shares |
0% |
Q1 2024 |
FY 2024 |
Common Stock, Shares, Issued |
1.85 M |
shares |
0% |
Q1 2024 |
FY 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
FY 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
30.8 K |
USD |
+186% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Valuation Allowance |
372 K |
USD |
+68.1% |
Q1 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2023 |
Q1 2023 |
Deferred Tax Assets, Gross |
321 K |
USD |
+85.3% |
Q1 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
4.18 K |
USD |
|
Q2 2023 |
Q1 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
80.1 K |
USD |
|
Q3 2022 |
Q2 2022 |
Deferred Federal Income Tax Expense (Benefit) |
2.98 K |
USD |
|
Q1 2024 |
Q4 2024 |
Unrecognized Tax Benefits |
0 |
USD |
-100% |
Q1 2023 |
FY 2023 |
Additional Paid in Capital |
795 K |
USD |
|
Q4 2022 |
Q3 2023 |
Current Federal Tax Expense (Benefit) |
613 K |
USD |
|
Q1 2024 |
Q4 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
80.1 K |
USD |
|
Q3 2022 |
Q2 2022 |